CAS 23672-07-3
:Levosulpirid
- (-)-5-Aminosulfonyl-N-[(1-Ethyl-2-Pyrrolidinyl)Methyl]-2-Methoxy-Benzamide
- (-)-N-1-[Ethylpyrrolidin-2-Ylmethyl]-2-Methoxy-5-Sulfamoylbenzamide
- (-)-Sulpiride
- (S)-(-)-5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolinyl)methyl]
- (S)-(-)-5-Aminosulfonyl-N-[(1-Ethyl-2-Pyrrolidinyl)Methyl]-2-Methoxybenzamide
- (S)-(-)-N-((1-Ethyl-2-Pyrrolidinyl)Methyl)-5-Sulfamoyl-O-Anisamide
- (S)-(-)-N-((1-Ethyl-2-Pyrrolidinyl)Methyl)-5-Sulfamoyl-O-Anisamide 5-(Aminosulfonyl)-N-((1-Ethyl-2-Pyrrolidinyl)Methyl)-2-Methoxy-Benzamid ( S-(-)-Benzamid
- (S)-(-)-Sulpiride
- (S)-(-)-Sulpiride, Vetranal
- 5-(Aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-methoxybenzamide
- <span class="text-smallcaps">L</span>-Sulpiride
- Benzamide, 5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-, (S)-
- Benzamide, 5-(aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-methoxy-
- Lesuride
- Levobren
- Levopraid
- Levopride
- Levosulpride
- N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-methoxy-5-sulfamoylbenzamide
- Rv-12309
- Rv-12309 S-(-)-N-(1-Ethyl-2-Pyrrolidinomethyl)-2-Methoxy-5-Sulfamoylebenzamide
- S(-)-Sulpiride Dopamine D1 Antagonis
- S-(-)-N-(1-Ethyl-2-Pyrrolidinomethyl)-2-Methoxy-5-Sulfamoylebenzamide
- Sulpid
- l-Sulpiride
- o-Anisamide, N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-, (-)-
- s-(-)-sulpiride (S)-5-Aminosulfonyl-N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxybenzamide
- LEVOSULPIRIDE/LEVOSULPRIDE
- (s)-(-)-o-anisamid
- LEVOSULPIRIDE
- Benzamide, 5-(aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-methoxy-(9CI)
- Weitere Synonyme anzeigen
(S)-(-)-Sulpiride
CAS:Formel:C15H23N3O4SReinheit:>98.0%(T)(HPLC)Farbe und Form:White to Light yellow powder to crystalMolekulargewicht:341.43N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-methoxy-5-sulfamoylbenzamide
CAS:Formel:C15H23N3O4SReinheit:98%Farbe und Form:SolidMolekulargewicht:341.4258Levosulpiride
CAS:Levosulpiride (S-(-)-Sulpiride) is the (S)-enantiomer of sulpiride, which is a D2 receptor antagonist, an atypical antipsychotic drug of the benzamide class.Formel:C15H23N3O4SReinheit:98.20% - 99.88%Farbe und Form:White Crystalline PowderMolekulargewicht:341.43Levosulpiride
CAS:Formel:C15H23N3O4SReinheit:98.0 - 102.0 %Farbe und Form:White to off-white powderMolekulargewicht:341.43S-(-)-Sulpiride
CAS:Kontrolliertes ProduktApplications Dopamine D2 and D3-receptor antagonist. Antipsychotic; antidepressant; antiemetic.
References Pitre, D., et al.: Anal. Profiles Drug Subs., 17, 607 (1988), Wagstaff, A.J., et al.: CNS Drugs, 2, 313 (1994),Formel:C15H23N3O4SFarbe und Form:WhiteMolekulargewicht:341.43Levopride
CAS:Applications Antipsychotic; antidepressant; antiemetic.
References Karolidis, D., et al.: Med. Chem., 6, 259 (2010), Cummings, D., et al.: J. Pharmacol. Exper. Ther., 335, 518 (2010),Formel:C15H23N3O4SFarbe und Form:WhiteMolekulargewicht:341.43Levosulpiride
CAS:Kontrolliertes ProduktLevosulpiride is a pharmacological agent which binds to dopamine (D2) receptors in the brain and gastrointestinal tract. It is used both to treat conditions that cause abnormal movements for e.g. Parkinson's disease and tardive dyskinesia, and also as an antiemetic and to treat certain gastric disorders. Additional to acting as a dopamine receptor antagonist, Levosulpiride also binds to α1-acid glycoprotein and has been shown to have a concentration-dependent effect on serum prolactin levels, with higher doses leading to increased levels, as well as an effect on basic fibroblasts.Formel:C15H23N3O4SReinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:341.43 g/molLevosulpiride - Bio-X ™
CAS:Kontrolliertes ProduktLevosulpiride is a pharmacological agent which binds to dopamine (D2) receptors in the brain and gastrointestinal tract. It is used both to treat conditions that cause abnormal movements for e.g. Parkinson's disease and tardive dyskinesia, and also as an antiemetic and to treat certain gastric disorders. Additional to acting as a dopamine receptor antagonist, Levosulpiride also binds to α1-acid glycoprotein and has been shown to have a concentration-dependent effect on serum prolactin levels, with higher doses leading to increased levels, as well as an effect on basic fibroblasts.
Formel:C15H23N3O4SReinheit:(%) Min. 95%Farbe und Form:PowderMolekulargewicht:341.43 g/mol











